Ontology highlight
ABSTRACT:
SUBMITTER: Salnikov OG
PROVIDER: S-EPMC7855180 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Salnikov Oleg G OG Chukanov Nikita V NV Svyatova Alexandra A Trofimov Ivan A IA Kabir Mohammad S H MSH Gelovani Juri G JG Kovtunov Kirill V KV Koptyug Igor V IV Chekmenev Eduard Y EY
Angewandte Chemie (International ed. in English) 20201201 5
Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [<sup>15</sup> N<sub>3</sub> ]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens o ...[more]